quantisnow
FeedTopReportsPricing
⌘K
Live feed
12:31:11·700d
NEWSRelease
Cytokinetics Incorporated logo
Altamira Therapeutics Ltd. logo
DermTech Inc. logo
+9

12 Health Care Stocks Moving In Thursday's Intraday Session

CYTK· Cytokinetics IncorporatedCYTO· Altamira Therapeutics Ltd.DMTK· DermTech Inc.HLTH· Cue Health Inc.ONMD· OneMedNet CorpPIII· P3 Health Partners Inc.
Health CareIndustrialsConsumer Discretionary
Original source

Companies

  • CYTK
    Cytokinetics Incorporated
    Health Care
  • CYTO
    Altamira Therapeutics Ltd.
    Health Care
  • DMTK
    DermTech Inc.
    Health Care
  • HLTH
    Cue Health Inc.
    Industrials
  • ONMD
    OneMedNet Corp
    Health Care
  • PIII
    P3 Health Partners Inc.
    Health Care
  • PPBT
    Purple Biotech Ltd.
    Health Care
  • PTIX
    Protagenic Therapeutics Inc.
    Health Care
  • QLI
    Qilian International Holding Group Ltd.
    Health Care
  • RENB
    Lunai Bioworks Inc.
    Health Care
  • SABS
    SAB Biotherapeutics Inc.
    Health Care
  • SILO
    Silo Pharma Inc.
    Consumer Discretionary

Recent analyst ratings

  • Apr 10CYTKUpdateWells Fargo$95.00
  • Apr 3SABSUpdateRodman & Renshaw$13.00
  • Apr 2SABSUpdateRodman & Renshaw$13.00
  • Jan 28CYTKUpdateBarclays$87.00
  • Dec 19SABSUpdateGuggenheim$15.00
  • Dec 18CYTKUpdateGoldman$95.00

Related

  • NEWS17h
    Protagenic Therapeutics Appoints Industry Veteran Bill Nichols Jr. as President to Accelerate Advancement of First-in-Class TCAP Pathway Therapy PT00114
  • SEC18h
    SEC Form 6-K filed by Purple Biotech Ltd.
  • PR19h
    Purple Biotech Establishes Scientific Advisory Board to Support Development of CAPTN-3 Tri-Specific Antibody Platform
  • PR1d
    OneMedNet Goes Live with 80 Million Patient Journeys and Billions of Records
  • SEC1d
    SAB Biotherapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
  • PR1d
    SAB BIO Presents Additional Clinical and Mechanistic Data from SAB-142 Phase 1 Trial in Adult Patients with Established Autoimmune Type 1 Diabetes at IDS 2026
  • INSIDER2d
    SEC Form 4 filed by Malik Fady Ibraham
  • PR2d
    Cytokinetics to Announce First Quarter Results on May 5, 2026
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022